GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile
GAME CHANGER Trial

@uq_gamechanger

ClinicalTrials.gov NCT03869437. RCT of Cefiderocol vs. SOC for treatment of HAI and HCAI Gram-negative bloodstream infections #UQCCR #MERINOgroup

ID: 1112563801625231360

linkhttps://clinical-research.centre.uq.edu.au/paterson-group calendar_today01-04-2019 03:54:15

32 Tweet

153 Followers

67 Following

GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

Great visual from Dr. Richard Alm’s CARB-X visit to #UQCCR highlighting the backbone antimicrobials play in sustaining modern medicine UQ Medicine #MERINOnetwork

Great visual from Dr. Richard Alm’s <a href="/CARB_X/">CARB-X</a> visit to #UQCCR highlighting the backbone antimicrobials play in sustaining modern medicine <a href="/UQMedicine/">UQ Medicine</a> #MERINOnetwork
GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

Another milestone for the GC Trial reached with our 250th participant enrolled today! Excellent work by Dr. Helmi Sulaiman Helmi Sulaiman and team @ UMMC, Malaysia for their consistently stellar support! #UQCCR #MERINOnetwork David Paterson

GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

A great way to finish a day with 3 enrolments within 1 hour! We are so lucky to work with amazing collaborators on this trial. David Paterson @MERINOnetwork f

GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

A brilliant milestone reached with the team at Taichung Veterans General Hospital in Taiwan recruiting #300 onto the trial! Thank you again to all our hardworking collaborators involved. David Paterson Patrick Harris #MERINOnetwork #UQCCR

SNAP Trial (@snap_trial) 's Twitter Profile Photo

After discussing progress of SNAP at #IDWeek2022 another milestone for SNAP! This time the enrolment was at the Royal Brisbane and Women's Hospital, team led by Bridget Barber. Steven Tong Joshua Davis

After discussing progress of SNAP at #IDWeek2022 another milestone for SNAP!
This time the enrolment was at the Royal Brisbane and Women's Hospital, team led by <a href="/Bridb3/">Bridget Barber</a>.

<a href="/syctong/">Steven Tong</a> <a href="/Josh_S_Davis/">Joshua Davis</a>
GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

Great to see such a pragmatic, impactful trial! Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a pragmatic, cluster-randomised trial in seven LMICs thelancet.com/journals/lance…

GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

Interesting RCT - Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial thelancet.com/journals/lance…

GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

FDA provides rationale for not accepting Polymyxin Breakpoints for Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp. einnews.com/article/611790… via صحيفة عين الأخبار

GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

Our 400th participant has been reached today! Great work Dr. Darunee Chotiprasitsakul and team @ Ramathibodi Hospital. Thank you all for keeping the momentum going on this trial’s final stretch! David Paterson Patrick Harris #MERINOnetwork UQ Medicine

Patrick Harris (@padstamundo) 's Twitter Profile Photo

Annette Hennigs Burcu Isler Yes and the testing can be technically challenging which also feeds uncertainty .. hopefully GAME CHANGER Trial RCT will help resolve some questions about clinical efficacy in bacteraemia and MDR-GNBs - will complete recruitment soon!

GAME CHANGER Trial (@uq_gamechanger) 's Twitter Profile Photo

500th participant enrolled! A huge achievement for this trial with so much gratitude for all our collaborators on getting us to this mark. LPI October 31st so watch this space for results coming the first half of 2024! David Paterson Patrick Harris UQ Medicine #MERINOgroup

NEJM (@nejm) 's Twitter Profile Photo

In this double-blind, randomized trial, vancomycin was added to cefazolin as surgical prophylaxis for arthroplasty. Surgical-site infections occurred in 4.5% of vancomycin recipients and 3.5% of placebo recipients. Full results of the ASAP trial: nej.md/3S4XNVU